Category Archives: Generics

MSF calls on Japan and South Korea to drop the harmful RCEP measures

Kobe, Japan/New Delhi 22 February 2017 As 16countries negotiating the Regional Comprehensive Economic Partnership (RCEP)agreement meet next week in Kobe, Japan, for the seventeenth round of negotiations, international medical humanitarian organisation Médecins Sans Frontières (MSF) is appealing tothe Japanese and South … Continue reading

Posted in Data Exclusivity, Drug prices, Generics, Patent Term Extension, Regional Comprehensive Economic Partnership, TRIPS, TRIPS plus, Uncategorized | Leave a comment

Pharma PSUs Are Not Ready To Die!

By Murali Neelakantan, BloombergQuintOpinion | February 7, 2017 The government’s decision to explore the strategic sale of Indian Drugs and Pharmaceuticals Ltd. and Bengal Chemicals – even as questions were asked of the move last week by parliamentarians including those from the BJP … Continue reading

Posted in Generics, Patent, Pricing, Uncategorized | Leave a comment

Indian pharma industry fears tougher US stance on IP

Prices of patented drugs are lower in Canada, United Kingdom and Australia in comparison to the US By Aneesh Phadnis & Reuters| Published: Business Standard | february 1, 2017 Indian pharma industry is fearing a tougher US government stance on intellectual … Continue reading

Posted in Generics, IPR, Uncategorized, US pressure on India | Leave a comment

Poor countries allowed to import generic drugs – WTO

By Tom Miles, Reuters | January 23, 2017 Poor countries are allowed to import generic medicines, World Trade Organization (WTO) Director General Roberto Azevedo told Reuters on Monday, after the required two-thirds of members agreed a deal that has taken … Continue reading

Posted in Generics, TRIPS, Uncategorized, WTO | Leave a comment

U.S. Supreme Court agrees to hear dispute over biologic drug sales

By Andrew Chung, Reuters The U.S. Supreme Court on Friday agreed to hear a dispute over whether companies that make copycat versions of biologic drugs must wait six months after winning federal approval to begin selling them. The justices will … Continue reading

Posted in Biologics/Biosimilars, Generics, Uncategorized | Leave a comment

On World AIDS Day, threat to access to medicines looms large

By Shailly Gupta, Jakarta Post| December 2, 2016 Today millions of people living with HIV in South-East Asia are receiving treatment and leading healthy lives thanks to affordable generic antiretroviral (ARVs) medicines. Governments and treatment providers across Asia, such as … Continue reading

Posted in Generics, HIV/Aids, IPR, Regional Comprehensive Economic Partnership, Tuberculosis (TB), Uncategorized | Leave a comment

Unhealthy delay

The Indian Express | October 28, 2016 PMO’s instruction to Niti Aayog to prepare plans to reduce dependence on China for bulk drugs may have come too late. Last week, the prime minister’s office instructed Niti Aayog to prepare a … Continue reading

Posted in API, Drug prices, Generics, Uncategorized | Leave a comment